Eli Lilly and Co
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s. Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly […]
Read More
Stocks making the biggest premarket moves: KeyCorp, Starbucks, JetBlue, Eli Lilly and more
Check out the companies making the biggest moves in premarket trading: KeyCorp — Shares of the Cleveland-based regional bank jumped 18% after the announcement of a minority investment from The Bank of Nova Scotia. The deal gives Scotiabank 14.9% of KeyCorp’s common stock for roughly $2.8 billion in cash. Starbucks — Shares of the coffee […]
Read More
Stocks making the biggest moves midday: Eli Lilly, Under Armour, Warner Bros. Discovery and more
Eli Lilly — The drug maker’s stock surged 8% after the firm reported second-quarter earnings and revenue that blew past expectations. Eli Lilly also hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Under Armour — Shares popped 19% after the athletic […]
Read More
Stocks making the biggest moves premarket: Eli Lilly, Under Armour, Warner Bros. Discovery and more
Check out the companies making headlines in premarket trading. Eli Lilly — The drug maker’s stock surged 8% in premarket trading after the firm reported second-quarter earnings and revenue that blew past expectations. Eli Lilly also hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss […]
Read More
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and […]
Read More
Stock futures fall after Wednesday’s afternoon market slide: Live updates
Stock market futures were little changed on Thursday morning as Wall Street sought to stabilize following several dramatic swings in recent days. Futures tied to the Dow Jones Industrial Average fell 17 points, or about 0.05%. S&P 500 futures slipped 0.12%, while Nasdaq 100 futures gained 0.1%. The move in futures comes after stocks were […]
Read More
Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching
Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its competing drug Wegovy in the second quarter. Novo Nordisk shocked investors on Wednesday when its latest results fell short of Wall Street’s expectations. Shares are reeling, down 8%, after […]
Read More
Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug […]
Read More
Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly‘s weight loss drug Zepbound showed benefits in patients with a common type of heart failure and obesity, according to late-stage trial data the company […]
Read More
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The list of potential health benefits from […]
Read More